Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
28 October 2021
The Executive Director of Sopharma met with Vice President of Vietnam Mrs. Vo Thi Anh Xuan
Financial News
20 December 2024
Decision on additional contribution to the capital of Sopharma Rus OOO
19 December 2024
Transaction within the scope of art. 114, para. 2 of the Law on Public offering of securities
19 December 2024
Sales revenues for November 2024
Financial Highlights 31 March, 2022
397 570
BGN '000 Revenue
34 368
BGN '000 EBITDA
21 827
BGN '000 Revenue from operating profit
22 560
BGN '000 Net profit for the year
0.17
BGN Earnings per share

Next events
20 January 2025
Financial revenues for January-December 2024
30 January 2025
Publication of Preliminary Annual Individual financial statements for 2024

Equity story

85+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A